vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Comstock Holding Companies, Inc. (CHCI). Click either name above to swap in a different company.

Comstock Holding Companies, Inc. is the larger business by last-quarter revenue ($23.9M vs $23.1M, roughly 1.0× ADC Therapeutics SA). On growth, Comstock Holding Companies, Inc. posted the faster year-over-year revenue change (41.5% vs 36.4%). Over the past eight quarters, Comstock Holding Companies, Inc.'s revenue compounded faster (50.0% CAGR vs 13.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

The Comstock Lode is a lode of silver ore located under the eastern slope of Mount Davidson, a peak in the Virginia Range in Virginia City, Nevada, which was the first major discovery of silver ore in the United States and named after Canadian miner Henry Comstock.

ADCT vs CHCI — Head-to-Head

Bigger by revenue
CHCI
CHCI
1.0× larger
CHCI
$23.9M
$23.1M
ADCT
Growing faster (revenue YoY)
CHCI
CHCI
+5.2% gap
CHCI
41.5%
36.4%
ADCT
Faster 2-yr revenue CAGR
CHCI
CHCI
Annualised
CHCI
50.0%
13.7%
ADCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
CHCI
CHCI
Revenue
$23.1M
$23.9M
Net Profit
$13.5M
Gross Margin
35.5%
Operating Margin
-77.7%
32.4%
Net Margin
56.3%
Revenue YoY
36.4%
41.5%
Net Profit YoY
30.5%
EPS (diluted)
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
CHCI
CHCI
Q4 25
$23.1M
$23.9M
Q3 25
$15.8M
$13.3M
Q2 25
$18.1M
$13.0M
Q1 25
$17.4M
$12.6M
Q4 24
$16.9M
$16.9M
Q3 24
$18.0M
$13.0M
Q2 24
$17.0M
$10.8M
Q1 24
$17.8M
$10.6M
Net Profit
ADCT
ADCT
CHCI
CHCI
Q4 25
$13.5M
Q3 25
$-41.0M
$541.0K
Q2 25
$-56.6M
$1.4M
Q1 25
$-38.6M
$1.6M
Q4 24
$10.3M
Q3 24
$-44.0M
$2.4M
Q2 24
$-36.5M
$946.0K
Q1 24
$-46.6M
$910.0K
Gross Margin
ADCT
ADCT
CHCI
CHCI
Q4 25
35.5%
Q3 25
11.0%
Q2 25
19.0%
Q1 25
18.6%
Q4 24
33.4%
Q3 24
26.3%
Q2 24
17.2%
Q1 24
16.5%
Operating Margin
ADCT
ADCT
CHCI
CHCI
Q4 25
-77.7%
32.4%
Q3 25
-196.6%
5.0%
Q2 25
-244.1%
13.7%
Q1 25
-163.5%
13.7%
Q4 24
-191.8%
30.1%
Q3 24
-197.4%
21.8%
Q2 24
-170.5%
11.4%
Q1 24
-188.3%
10.8%
Net Margin
ADCT
ADCT
CHCI
CHCI
Q4 25
56.3%
Q3 25
-260.1%
4.1%
Q2 25
-313.2%
11.1%
Q1 25
-221.8%
12.6%
Q4 24
61.1%
Q3 24
-244.1%
18.3%
Q2 24
-214.6%
8.8%
Q1 24
-261.1%
8.6%
EPS (diluted)
ADCT
ADCT
CHCI
CHCI
Q4 25
$0.04
Q3 25
$-0.30
Q2 25
$-0.50
Q1 25
$-0.36
Q4 24
$-0.26
Q3 24
$-0.42
Q2 24
$-0.38
Q1 24
$-0.56
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
CHCI
CHCI
Cash + ST InvestmentsLiquidity on hand
$261.3M
$31.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$70.0M
Total Assets
$323.1M
$85.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
CHCI
CHCI
Q4 25
$261.3M
$31.3M
Q3 25
$234.7M
$26.2M
Q2 25
$264.6M
$30.5M
Q1 25
$194.7M
$28.3M
Q4 24
$250.9M
$28.8M
Q3 24
$274.3M
$21.1M
Q2 24
$300.1M
$17.4M
Q1 24
$234.3M
$16.2M
Stockholders' Equity
ADCT
ADCT
CHCI
CHCI
Q4 25
$-185.8M
$70.0M
Q3 25
$-238.2M
$56.3M
Q2 25
$-199.2M
$55.5M
Q1 25
$-238.2M
$53.7M
Q4 24
$-202.6M
$52.4M
Q3 24
$-171.9M
$41.7M
Q2 24
$-131.7M
$39.2M
Q1 24
$-194.4M
$37.9M
Total Assets
ADCT
ADCT
CHCI
CHCI
Q4 25
$323.1M
$85.0M
Q3 25
$289.8M
$67.6M
Q2 25
$321.6M
$65.2M
Q1 25
$272.5M
$62.8M
Q4 24
$322.0M
$64.9M
Q3 24
$349.1M
$52.2M
Q2 24
$371.8M
$48.6M
Q1 24
$308.0M
$46.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
CHCI
CHCI
Operating Cash FlowLast quarter
$-31.1M
$4.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.36×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
CHCI
CHCI
Q4 25
$-31.1M
$4.8M
Q3 25
$-29.6M
$-3.2M
Q2 25
$-24.1M
$2.2M
Q1 25
$-56.3M
$582.0K
Q4 24
$-21.9M
$10.7M
Q3 24
$-25.0M
$3.9M
Q2 24
$-32.8M
$1.3M
Q1 24
$-44.1M
$-2.2M
Free Cash Flow
ADCT
ADCT
CHCI
CHCI
Q4 25
Q3 25
Q2 25
Q1 25
$-56.6M
Q4 24
$-21.9M
Q3 24
$-25.3M
Q2 24
$-32.9M
Q1 24
$-44.6M
FCF Margin
ADCT
ADCT
CHCI
CHCI
Q4 25
Q3 25
Q2 25
Q1 25
-325.2%
Q4 24
-129.8%
Q3 24
-140.2%
Q2 24
-193.0%
Q1 24
-250.0%
Capex Intensity
ADCT
ADCT
CHCI
CHCI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
1.5%
Q4 24
0.5%
Q3 24
1.2%
Q2 24
0.2%
Q1 24
3.0%
Cash Conversion
ADCT
ADCT
CHCI
CHCI
Q4 25
0.36×
Q3 25
-5.96×
Q2 25
1.51×
Q1 25
0.37×
Q4 24
1.03×
Q3 24
1.63×
Q2 24
1.35×
Q1 24
-2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

CHCI
CHCI

Related Party$22.1M92%
Nonrelated Party$1.9M8%

Related Comparisons